154 related articles for article (PubMed ID: 38216411)
1. I see, therefore I am? The value of artificial intelligence in nuclear imaging-based identification of cardiac amyloidosis.
Kersting D; Rischpler C; Seifert R
J Nucl Cardiol; 2024 Mar; 33():101773. PubMed ID: 38216411
[No Abstract] [Full Text] [Related]
2. Trends in Diagnostic Imaging of Cardiac Amyloidosis: Emerging Knowledge and Concepts.
Oda S; Kidoh M; Nagayama Y; Takashio S; Usuku H; Ueda M; Yamashita T; Ando Y; Tsujita K; Yamashita Y
Radiographics; 2020; 40(4):961-981. PubMed ID: 32442047
[TBL] [Abstract][Full Text] [Related]
3. Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis.
Falk RH; Dorbala S
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):467-9. PubMed ID: 21267559
[No Abstract] [Full Text] [Related]
4. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
Brownrigg J; Lorenzini M; Lumley M; Elliott P
ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
[TBL] [Abstract][Full Text] [Related]
5. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.
Aljaroudi WA; Desai MY; Tang WH; Phelan D; Cerqueira MD; Jaber WA
J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127
[TBL] [Abstract][Full Text] [Related]
6. The Role of Cardiac MR Imaging in the Assessment of Patients with Cardiac Amyloidosis.
Carvalho FP; Erthal F; Azevedo CF
Magn Reson Imaging Clin N Am; 2019 Aug; 27(3):453-463. PubMed ID: 31279449
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis.
Liu D; Niemann M; Hu K; Herrmann S; Störk S; Knop S; Ertl G; Weidemann F
Am J Cardiol; 2011 Aug; 108(4):591-8. PubMed ID: 21807135
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of amyloidosis: will the heart be the next target after the brain?
Chen W; Dilsizian V
Curr Cardiol Rep; 2012 Apr; 14(2):226-33. PubMed ID: 22193845
[TBL] [Abstract][Full Text] [Related]
9. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
[TBL] [Abstract][Full Text] [Related]
10. Identification and Assessment of Cardiac Amyloidosis by Myocardial Strain Analysis of Cardiac Magnetic Resonance Imaging.
Oda S; Utsunomiya D; Nakaura T; Yuki H; Kidoh M; Morita K; Takashio S; Yamamuro M; Izumiya Y; Hirakawa K; Ishida T; Tsujita K; Ueda M; Yamashita T; Ando Y; Hata H; Yamashita Y
Circ J; 2017 Jun; 81(7):1014-1021. PubMed ID: 28367859
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic imaging of cardiac amyloidosis.
Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
[TBL] [Abstract][Full Text] [Related]
12. Cardiac amyloidosis. Two main subtypes and diagnosis by Nuclear Medicine: SPET tracer revival.
Valsamaki PN; Zissimopoulos A
Hell J Nucl Med; 2019; 22(3):161-164. PubMed ID: 31587024
[No Abstract] [Full Text] [Related]
13. Machine Learning Approaches in Diagnosis, Prognosis and Treatment Selection of Cardiac Amyloidosis.
Allegra A; Mirabile G; Tonacci A; Genovese S; Pioggia G; Gangemi S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982754
[TBL] [Abstract][Full Text] [Related]
14. Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.
Khor YM; Cuddy S; Falk RH; Dorbala S
Semin Nucl Med; 2020 Jul; 50(4):295-310. PubMed ID: 32540027
[TBL] [Abstract][Full Text] [Related]
15. The utility of positron emission tomography in cardiac amyloidosis.
Saeed S; Saad JM; Ahmed AI; Han Y; Al-Mallah MH
Heart Fail Rev; 2022 Sep; 27(5):1531-1541. PubMed ID: 34743267
[TBL] [Abstract][Full Text] [Related]
16. [Non-invasive diagnosis of cardiac amyloidosis due to transthyretin. Case report].
Povar Echeverría M; Auquilla Clavijo PE; Escobedo Palau JA; Navarro Beltrán P; Povar Marco J
An Sist Sanit Navar; 2018 Aug; 41(2):263-267. PubMed ID: 29943762
[TBL] [Abstract][Full Text] [Related]
17. Atrial thrombosis in cardiac amyloidosis: diagnostic contribution of transesophageal echocardiography.
Santarone M; Corrado G; Tagliagambe LM; Manzillo GF; Tadeo G; Spata M; Longhi M
J Am Soc Echocardiogr; 1999 Jun; 12(6):533-6. PubMed ID: 10359926
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.
White JA; Fine NM
Curr Cardiol Rep; 2016 Aug; 18(8):77. PubMed ID: 27319007
[TBL] [Abstract][Full Text] [Related]
19. [18F]-NaF PET/CT imaging in cardiac amyloidosis.
Van Der Gucht A; Galat A; Rosso J; Guellich A; Garot J; Bodez D; Plante-Bordeneuve V; Hittinger L; Dubois-Randé JL; Evangelista E; Sasanelli M; Chalaye J; Meignan M; Itti E; Damy T
J Nucl Cardiol; 2016 Aug; 23(4):846-9. PubMed ID: 26403145
[TBL] [Abstract][Full Text] [Related]
20. The year in cardiovascular medicine 2021: imaging.
Bucciarelli-Ducci C; Ajmone-Marsan N; Di Carli M; Nicol E
Eur Heart J; 2022 Mar; 43(13):1288-1295. PubMed ID: 35259251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
